Gene-Targeted Medications
Gene-targeted medications are drugs that selectively block the growth and spread of cancer without affecting the healthy cells. Targeted therapies interfere with cancer cell growth differently than cytotoxic chemotherapy and at various points during the development, growth, and spread of cancer. By switching off the signals that make cancer cells grow and divide uncontrollably, targeted cancer therapies can help stop the growth of cancer cells.
Targeted medications have shown to be easier tolerated than standard chemotherapy and radiation with no side effects or minimal adverse reactions noted.
There are currently over 20 targeted therapeutics approved by the FDA (as of June 2007). This number grows rapidly with the advancement of the research in genomics. All of the approved gene-targeted medications are available for treatment at the Burzynski Clinic. The combination of targeted medications is customized for each patient and determined by the type of oncogenes involved in patient’s cancer (Personalized Treatment Programs)..